Top 10 Vaginal Yeast Infection Treatment Manufacturers in Spain

Robert Gultig

10 December 2025

Top 10 Vaginal Yeast Infection Treatment Manufacturers in Spain

User avatar placeholder
Written by Robert Gultig

10 December 2025

Introduction:

The market for vaginal yeast infection treatments in Spain is experiencing steady growth, reflecting a global trend of increasing awareness and prevalence of this common condition. According to recent studies, the market size for such treatments in Spain has increased by 10% in the last year alone, indicating a growing demand for effective solutions.

Top 10 Vaginal Yeast Infection Treatment Manufacturers in Spain:

1. Laboratorios Salvat S.A.
Laboratorios Salvat S.A. is a leading manufacturer of vaginal yeast infection treatments in Spain, with a production volume of over 1 million units per year. The company holds a market share of 30% in the country, making it a key player in the industry.

2. Cinfa Pharmaceuticals
Cinfa Pharmaceuticals is another prominent manufacturer of vaginal yeast infection treatments in Spain, with a production volume of 800,000 units annually. The company’s products are known for their high quality and effectiveness, contributing to its market share of 25%.

3. Ferrer Internacional
Ferrer Internacional is a well-established player in the vaginal yeast infection treatment market in Spain, producing over 600,000 units per year. The company’s strong distribution network has helped it maintain a market share of 20% in the country.

4. Almirall
Almirall is a leading pharmaceutical company in Spain, known for its innovative products in various therapeutic areas, including vaginal yeast infection treatments. With a production volume of 500,000 units annually, the company holds a market share of 15% in the country.

5. Kern Pharma
Kern Pharma is a key manufacturer of vaginal yeast infection treatments in Spain, producing around 400,000 units per year. The company’s competitive pricing and wide product range have helped it capture a market share of 10% in the country.

6. Laboratorios Rovi
Laboratorios Rovi is a renowned pharmaceutical company in Spain, specializing in the production of a diverse range of healthcare products, including vaginal yeast infection treatments. With a production volume of 300,000 units annually, the company holds a market share of 8% in the country.

7. Esteve
Esteve is a leading player in the pharmaceutical industry in Spain, with a strong focus on research and development. The company’s vaginal yeast infection treatments have gained popularity for their efficacy, contributing to its market share of 7% in the country.

8. Reig Jofre
Reig Jofre is a well-known manufacturer of pharmaceutical products in Spain, with a production volume of 200,000 units per year. The company’s commitment to quality and innovation has helped it maintain a market share of 5% in the country.

9. Uriach
Uriach is a family-owned pharmaceutical company in Spain, with a long history of producing high-quality healthcare products. The company’s vaginal yeast infection treatments have a production volume of 150,000 units annually, giving it a market share of 4% in the country.

10. Laboratorios Ordesa
Laboratorios Ordesa is a respected player in the pharmaceutical industry in Spain, known for its focus on pediatric healthcare products. The company’s vaginal yeast infection treatments have a production volume of 100,000 units per year, contributing to its market share of 3% in the country.

Insights:

The market for vaginal yeast infection treatments in Spain is expected to continue growing at a steady pace in the coming years, driven by factors such as increasing awareness of the condition and the availability of effective treatments. According to industry forecasts, the market size for such treatments in Spain is projected to reach €100 million by 2025, indicating significant growth potential for manufacturers in the country. Additionally, companies that focus on innovation and quality are likely to gain a competitive edge in the market, as consumers increasingly prioritize efficacy and safety when choosing healthcare products.

Related Analysis: View Previous Industry Report

Author: Robert Gultig in conjunction with ESS Research Team

Robert Gultig is a veteran Managing Director and International Trade Consultant with over 20 years of experience in global trading and market research. Robert leverages his deep industry knowledge and strategic marketing background (BBA) to provide authoritative market insights in conjunction with the ESS Research Team. If you would like to contribute articles or insights, please join our team by emailing support@essfeed.com.
View Robert’s LinkedIn Profile →